Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Emerging technologies in regenerative medicine have the potential to restore the β-cell compartment in diabetic patients, thereby overcoming the inadequacies of current treatment strategies and organ supply. Novel approaches include: 1) Encapsulation technology that protects islet transplants from host immune surveillance; 2) stem cell therapies and cellular reprogramming, which seek to regenerate the depleted β-cell compartment; and 3) whole-organ bioengineering, which capitalizes on the innate properties of the pancreas extracellular matrix to drive cellular repopulation. Collaborative efforts across these subfields of regenerative medicine seek to ultimately produce a bioengineered pancreas capable of restoring endocrine function in patients with insulin-dependent diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microencapsulated Islets as Bioartificial Endocrine Pancreas
Lim, F., & Sun, A. M. (1980) · Science · doi:10.1126/science.6776628 · Cited by 2,377 · cited 1×
“In most studies to date, alginate beads were coated with a second layer to reduce the porosity of the capsule membrane (17,28); in some studies, alternating layers of poly-L-lysine and polyornithine were used to surround the alginate core but mechanical instability was described, thereby limiting their application (17…”
BackgroundIn vivo reprogramming of adult pancreatic exocrine cells to β-cells
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., & Melton, D. A. (2008) · Nature · doi:10.1038/nature07314 · Cited by 2,010 · cited 1×
“(112) came up with a combination of three key pancreatic transcription factors, Pdx1, Ngn3, and MafA (also used with some success in earlier liver-to-pancreas reprogramming attempts), that, when shuttled aboard adenoviral vector and injected into the pancreatic parenchyma, gave rise to new b-cells in vivo.”
BackgroundInternational trial of the Edmonton protocol for islet transplantation
Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942 · cited 1×
“Although the majority of patients reached insulin independence following transplantation, few managed to maintain euglycemia at 2-year follow-up (119).”
BackgroundSelf-citationKroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843 · cited 1×
“By doing so, the recipient’s body provides a microenvironment that is permissive for their efficient functional maturation, even if the process is neither short nor safe (47).”
BackgroundGeneration of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
Efficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273
Voltarelli, J. C., Couri, C. E. B., Stracieri, A. B. P. L., Oliveira, M. C., Moraes, D. A., Pieroni, F., Coutinho, M., Malmegrim, K. C. R., Foss-Freitas, M. C., Simões, B. P., et al. (2007) · JAMA · doi:10.1001/jama.297.14.1568 · Cited by 573 · cited 1×
“Thus, they have been successfully tested for their ability to reset the immunological clock of diabetes (88,89).”
BackgroundOrgan engineering based on decellularized matrix scaffolds
Song, J. J., & Ott, H. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.005 · Cited by 501 · cited 1×
“The pancreatic ECM is a three-dimensional, structural framework of proteins in a state of “dynamic reciprocity” with the cells of the endocrine pancreas (115).”
BackgroundMeans, A. L., Meszoely, I. M., Suzuki, K., Miyamoto, Y., Rustgi, A. K., Coffey, R. J., Wright, C. V. E., Stoffers, D. A., & Leach, S. D. (2005) · Development · doi:10.1242/dev.01925 · Cited by 344
Cited by
Zhou, Q., & Melton, D. A. (2018) · Nature · doi:10.1038/s41586-018-0088-0 · Cited by 385
Kwon, H., Kim, M., Seo, Y., Moon, Y. S., Lee, H. J., Lee, K., & Lee, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.034 · Cited by 208
Peloso, A., Urbani, L., Cravedi, P., Katari, R., Maghsoudlou, P., Fallas, M. E. A., Sordi, V., Citro, A., Purroy, C., Niu, G., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001364 · Cited by 133
“that ECM scaffolds generated from native pancreas tissue can serve as a platform for insulin-producing bioengineered tissue.(4,18,25) The importance of transitioning to human organs is obvious in the context of clinical relevance.”
BackgroundSelf-citationYang, K., O’Cearbhaill, E. D., Liu, S. S., Zhou, A., Chitnis, G. D., Hamilos, A. E., Xu, J., Verma, M. K. S., Giraldo, J. A., Kudo, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101258118 · Cited by 58
“Examples include prevascularization of the device, infusion of vascular endothelial growth factor, and cotransplantation of mesenchymal stem cells (15, 18 – 21).”
Comprehensive characterization of the human pancreatic proteome for bioengineering applications
Asthana, A., Tamburrini, R., Chaimov, D., Gazia, C., Walker, S. J., Van Dyke, M., Tomei, A., Lablanche, S., Robertson, J., Opara, E. C., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120613 · Cited by 33
Self-citation
Metadata
- Authors
- Orlando, G., Gianello, P., Salvatori, M., Stratta, R. J., Soker, S., Ricordi, C., & Domínguez-Bendala, J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-04-12
- Volume
- 63
- Issue
- 5
- Pages
- 1433-1444
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2117864832
- Cited by
- 53
- References
- 11
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/db13-1742
- The paper
- Orlando, G., Gianello, P., Salvatori, M., Stratta, R. J., Soker, S., Ricordi, C., & Domínguez-Bendala, J. (2014). Cell Replacement Strategies Aimed at Reconstitution of the β-Cell Compartment in Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db13-1742
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.